The ARDS Stem Cell Treatment Consists of the Following:
Spirometry and Chest CT then analysis with our internist
300 Million Stem Cell IV
4 Sessions of 25 million MSCs via Nebulizer
NAD+ and High Dose Vitamin C IV drip after the stem cells
PRICE: $17,490 USD
- Day 1: Arrive and Rest
- Day 2: Bloodwork, spirometry test & chest x-ray
- Day 3: Review scans with our internist to clear you for treatment. (They reserve the right to deny treatment if they believe your body can’t handle treatment)
- Day 4: Free Day. We have to take the cells out of cultivation for treatments the next day.
- Day 5: IV Stem Cell Treatment + 2nd Nebulized Session.
- Day 6: We can do 2 Nebulized sessions this day with one in the morning and one in the afternoon.
- Day 7: Fly Home (We recommend staying one more day to rest, but you can leave on this day)
If you are in town for more than 7 days then the itinerary may not be all consecutive days. Please select accommodations in Bucerias or Nuevo Vallarta as this treatment requires a lot of back and forth transportation.
The ARDS Stem Cell Treatment at Dream Body Clinic
Looking for a revolutionary way to treat Acute Respiratory Distress Syndrome (ARDS)?
With our advanced ARDS stem cell treatment, we can help reduce inflammation, promote tissue repair, and improve lung function. Our treatment is based on the use of mesenchymal stem cells, which have shown incredible results in reducing mortality rates associated with ARDS.
At Dream Body Clinic, we understand that ARDS can be a life-threatening condition that requires rapid intervention. That’s why our team of experienced medical professionals is dedicated to providing prompt, effective, and scientifically proven treatment options.
We use Wharton Jelly (umbilical cord tissue) and placenta to derive our pure, isolated MSCs. Then we cultivate them to get the hundreds of millions necessary for this advanced treatment. The MSCs are then safely infused into your body to facilitate natural healing and regeneration. MSCs also release growth factors and cytokines that promote tissue regeneration, reduce inflammation, and modulate the immune response, all of which are crucial for pulmonary health.
Our treatment is minimally invasive, requires little or no downtime, and is accompanied by minimal discomfort. You can rest assured that you are in good hands with our skilled and experienced team, who will guide and support you every step of the way.
With Dream Body Clinic’s ARDS stem cell treatment, you can take the first step towards restoring your respiratory health and achieving your dream body. Why wait? Schedule your consultation today and see why we are the leader in innovative stem cell treatments for ARDS.
Call (888) 407-3977 For a Free Consultation
You can also email us at info@dreambodyclinic.net
how do mesenchymal stem cells work for Acute Respiratory Distress Syndrome?
Mesenchymal stem cells (MSCs) have shown potential for treating Acute Respiratory Distress Syndrome (ARDS). ARDS is a severe lung injury caused by inflammation, leading to damage to the alveoli (tiny air sacs in the lungs) and impaired oxygen exchange, resulting in severe breathing problems. MSCs can suppress inflammation and promote tissue repair, making them a potentially effective treatment for ARDS.
When injected intravenously into the bloodstream, MSCs reach the lungs and begin to act on various cell types involved in the inflammation response. MSCs secrete anti-inflammatory cytokines (proteins that control the immune response) and growth factors, which reduce inflammation, promote tissue regeneration, and repair the damaged alveoli. MSCs also have a paracrine effect, which means they can signal to neighboring cells to promote tissue regeneration and keep the lung tissue healthy.
MSCs have been observed to reduce the inflammation and increase the survival rate of people with ARDS. MSCs have also been used in clinical trials with ARDS patients, where they have shown potential in improving oxygen saturation and reducing the need for mechanical ventilation.
In summary, MSCs can mitigate the inflammation response caused by ARDS and promote lung tissue repair, making them an exceptional therapeutic option for ARDS patients.
How do Mesenchymal Stem Cells Help Alveoli in ARDS?
MSCs secrete anti-inflammatory molecules, such as interleukin-10, transforming growth factor-beta, and prostaglandin E2, that can reduce inflammation in the lungs and alveoli. By reducing inflammation, the damage to the alveoli is reduced, and their ability to exchange gases in the lungs is improved.
Additionally, MSCs can differentiate into various cell types needed for tissue repair and regeneration, including type II pneumocytes. These cells are responsible for producing surfactant, a substance that reduces surface tension in the alveoli, allowing them to expand during inhalation and preventing them from collapsing during exhalation. This surfactant production can improve lung function and prevent further damage to the alveoli.
In preclinical studies, MSCs have been shown to reduce inflammation and promote tissue regeneration in the lungs, leading to improved oxygen exchange and reduced mortality rates. These promising results suggest that MSCs could be a valuable tool in treating ARDS and improving lung function.
How do the Interleukin-10 Released by MSCs Help Lung Repair in ARDS
Interleukin-10 (IL-10) is an anti-inflammatory cytokine released by MSCs (mesenchymal stem cells) that can help in lung repair during ARDS (Acute Respiratory Distress Syndrome).
During ARDS, the alveoli in the lungs become inflamed and damaged, leading to a reduction in their ability to exchange gases. This inflammation is caused by an overactive immune response, which can be detrimental to alveolar tissue and lung function.
When MSCs are administered to a patient with ARDS, they can help reduce inflammation by secreting IL-10. IL-10 is a potent anti-inflammatory cytokine that inhibits the activity of pro-inflammatory cytokines such as TNF-alpha, Interleukin-1, and Interleukin-6. By inhibiting the activity of these cytokines, IL-10 reduces inflammation in the lungs, which can help reduce damage to alveolar tissue and prevent further loss of lung function.
In addition to its anti-inflammatory effects, IL-10 can also promote tissue repair. It can stimulate the growth and differentiation of type II pneumocytes which are responsible for producing surfactant in the alveoli. Surfactant is a vital component of the lungs that maintains their structural integrity and prevents the alveoli from collapsing.
By releasing IL-10, MSCs can suppress inflammation and promote tissue repair, which can help reverse the damage caused by ARDS and restore normal lung function.
In summary, IL-10 released by MSCs can help lung repair in ARDS by reducing inflammation and promoting tissue repair. By inhibiting pro-inflammatory cytokines and promoting the growth and differentiation of type II pneumocytes, IL-10 can help restore normal lung function and improve the outcomes for patients with ARDS.
How do Transforming Growth Factor-Beta Released by MSCs Help Lung repair in ARDS?
Transforming growth factor-beta (TGF-beta) is a powerful cytokine released by Mesenchymal stem cells (MSCs) that contributes to lung repair during Acute Respiratory Distress Syndrome (ARDS). TGF-beta plays a crucial role in modulating inflammation and triggering tissue regeneration and remodeling.
During ARDS, alveolar tissue is damaged due to inflammation, which hampers their normal functioning, making it difficult for proper gas exchange. When MSCs are introduced into the bloodstream, they get to the site of injury and release TGF-beta, which promotes the proliferation of fibroblasts, endothelial cells, and epithelial cells that take part in tissue repair.
TGF-beta serves as a chemoattractant molecule for monocytes, T-cells, and other cells of the immune system, which results in regulatory cell-type differentiation, improving the anti-inflammatory milieu at the site of injury. TGF-beta also acts on fibroblasts, causing them to secrete collagen, which forms new extracellular matrix, aiding in tissue repair. Furthermore, TGF-beta stimulates vascular endothelial growth factor (VEGF) secretion, which helps stimulate blood vessel formation and angiogenesis, promoting neovascularization and aiding in tissue repair.
Additionally, TGF-beta promotes fibrosis, which, in excessive amounts, can be harmful. Research has suggested that MSCs with reduced TGF-beta expression can be used to avoid excessive fibrosis.
In summary, TGF-beta released by MSCs coordinates a broad array of processes that help to reduce inflammation, promote tissue repair, and angiogenesis, contributing to lung repair during ARDS. By stimulating the proliferation of fibroblasts, endothelial and epithelial cells, regulating cell differentiation, and inducing collagen synthesis, TGF-beta aids in restoring normal lung tissue architecture and function.
How do prostaglandin E2 Released by MSCs Help Lung Repair in ARDS?
Prostaglandin E2 (PGE2) is a lipid mediator that is produced by Mesenchymal stem cells (MSCs) and plays a vital role in lung repair during Acute Respiratory Distress Syndrome (ARDS). PGE2 is a potent anti-inflammatory molecule that can reduce inflammation and contribute to the repair of damaged tissues.
During ARDS, excessive inflammation leads to injury and damage to the alveolar epithelium and endothelium. When MSCs are introduced into the bloodstream, they migrate to the lungs and release PGE2, which helps reduce inflammation by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and Interleukin-6. PGE2 also increases the production of anti-inflammatory cytokines and enhances phagocytosis, making it easier for the body to clear out damaged cells and debris.
PGE2 can also promote tissue repair by regulating the proliferation and differentiation of lung cells such as alveolar epithelial cells and Type II pneumocytes. It can stimulate the differentiation of lung cells into surfactant-producing type II pneumocytes, which help prevent alveolar collapse during exhalation. PGE2 can also stimulate the growth of endothelial cells, leading to the formation of new blood vessels, which helps improve oxygenation and blood flow to the damaged tissues of the lungs.
Furthermore, PGE2 has been shown to have immunomodulatory properties, which can help the body’s immune system maintain a healthy balance between the pro-inflammatory and anti-inflammatory processes. This balance is necessary to prevent the development of severe inflammation, which can lead to lung damage.
In summary, PGE2 released by MSCs plays an essential role in lung repair during ARDS by reducing inflammation, promoting tissue repair, and improving the balance between pro-inflammatory and anti-inflammatory processes. By regulating the proliferation and differentiation of lung cells, stimulating the growth of endothelial cells, reducing inflammation, PGE2 can aid in the recovery of respiratory function after ARDS.
ARDS Mesenchymal Stem Cell Studies
Side Effects or Risks
The only side effects that have been documented are the following:
- 1 in 100 people will experience a slight fever and/or headache for a few hours after treatment or the next day. We have found that 500mg of Tylenol easily resolves this issue.
- Any treatment involving an injection such as an IV runs a risk of infection. We have never had a patient experience an infection due to our sterility protocols,.
- We do not treat patients that have had cancer within the past 5 years. There is still no conclusive evidence linking stem cells to make cancer worse, but we prefer to stay on the side of safety until more information is available.
- As with any medical treatment there is no guarantee of results, but our outcomes have been great for the vast majority of patients.
- In all patients who receive an intravenous treatment of any sort, there is a risk of releasing a thrombus or plaque from the veins, even more so if the patient has mainly high cholesterol levels. If a thrombosis or phlebitis were to occur, it would occur immediately. This has not been an issue with our patients, but any sort of IV has this risk. This is why we do bloodwork for all patients to make sure that treatment is as safe as possible for them.
Our lab has over 8 years of experience cultivating mesenchymal stem cells with perfect safety and efficacy. See Stem Cell Certification by Clicking Here
How long do the ARDS Stem Cell Treatment Results Last?
The results from the ARDS stem cell treatment can last for years or even indefinitely. This is because the stem cells are creating real cellular regeneration. Any improvement to your lung tissue will last because it is new pulmonary tissue. The stem cells will also reprogram your immune system to work the way it was designed to work. Once the immune cells are reprogrammed and any damage is repaired at the lungs, then things will work the way they should. This will last because it is real regeneration and not just a pill to cover up symptoms.
The mesenchymal stem cells that are administered via IV will stay in the system for 8 months to a year. During that time they will interact with immune cells and seek out inflammation where they will guide cellular regeneration. After 8 to 12 months any MSCs that are free bound in your system will differentiate into an osteoblast (bone cell), adipocyte (fat cell) or chondrocyte (cartilage cell). They will then contain the donors HLA markers and your immune system will destroy and remove them. This is an easy process for your immune system and there is no negative reaction in your body from it. Some of the MSCs that were free bound from the IV will find capillaries to call home. They will attach and be considered a pericyte. When they do this they can live in your system indefinitely in a beneficial way to your system.
The ARDS Stem Cell Treatment is allowing your body to heal like it did when you were a little kid.
How to get the ARDS Stem Cell Treatment
In conclusion, ARDS stem cell treatment could be a promising solution for individuals who are facing this condition. The Dream Body Clinic provides personalized treatment plans using stem cells to repair and regenerate damaged tissues of the lungs, which may lead to improved respiratory function and overall lung function. While this treatment is not yet widely available, ongoing research suggests that it could be a viable alternative to traditional kidney disease management methods. If you are interested in learning more about this treatment, we recommend calling us for a free consultation at (888) 704-3977. If you are ready to get the ARDS Stem Cell Treatment then click the image below for details on how to book.
